![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medicover Ab | LSE:0RPS | London | Ordinary Share | SE0009778848 | MEDICOVER ORD SHS CLASS B |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 81.20 | 79.20 | 83.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 1.75B | 17.6M | 0.2412 | 75.95 | 1.34B |
STOCKHOLM, April 30, 2020 /PRNewswire/ --
REVENUE AND EARNINGS
€ millions (€m) | Q1 2020 | Q1 2019 | Variance | FY 2019 |
Revenue | 238.8 | 199.7 | 20% | 844.4 |
Operating profit (EBIT) | 6.4 | 11.3 | -43% | 46.5 |
Operating profit margin | 2.7% | 5.6% | 5.5% | |
Net result | -2.5 | 6.9 | -136% | 24.7 |
Net result margin | -1.0% | 3.4% | 2.9% | |
Basic/diluted earnings/(loss) per share, € | -0.006 | 0.046 | -113% | 0.168 |
EBITDA | 29.0 | 27.5 | 6% | 120.7 |
EBITDA margin | 12.2% | 13.8% | 14.3% | |
EBITDAaL | 16.8 | 18.5 | -9% | 80.6 |
EBITDAaL margin | 7.0% | 9.2% | 9.5% | |
EBITA | 8.9 | 12.5 | -29% | 53.7 |
EBITA margin | 3.7% | 6.3% | 6.4% |
Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information. As from Q3 2019 margins (including margins of comparative figures) and growth rates have been calculated based on EUR whole figures instead of figures rounded in millions.
This is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact person set out below at 7.45 (CEST) on 30 April 2020. This interim report and other information about Medicover is available at medicover.com.
Contact information
For further information, please contact:
Hanna Bjellquist
Head of Investor Relations
Phone: +46-70-303-32-72
E-mail: hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2019, Medicover had revenue around €844 million and 28,800 employees. For more information, go to www.medicover.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medicover/r/interim-report-january-march-2020,c3101087
The following files are available for download:
https://mb.cision.com/Main/15662/3101087/1239343.pdf | Interim report January-March 2020 |
Copyright 2020 PR Newswire
1 Year Medicover Ab Chart |
1 Month Medicover Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions